PATENT CLAIM ANALYSIS

Application Number: 16057187
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["435", "006000"]

Abstract:
The present invention provides substituted pyrrolo-, furano-, and cyclopentylpyrimidine bicyclic compounds of Formula III, and Formula IV, and pharmaceutically acceptable salts, solvates, and hydrates thereof, having antimitotic activity, anti-multidrug resistance activity, such as for example P-glycoprotein inhibition, and antitumor activity, and which inhibit paclitaxel sensitive and resistant tumor cells. Also provided are methods of utilizing these compounds and pharmaceutical compositions for treating tumor cells and inhibiting mitosis of cancerous cells.

Claim (Index 4):
The pharmaceutical composition of  claim 3  wherein Y is nitrogen, R 1  is either a methoxyphenyl group when R 2  is a methyl group, or R 1  is a methyl group when R 2  is a methoxyphenyl group, and wherein R 3  is NH 2 , and R 6  is a hydrogen, and R 5  is a methyl group, and the bond between positions 5 and 6 is a single bond, and X is R 7 CR 4  wherein R 7  and R 4  are each H.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 96.0
- Lexical Diversity: 1.53704
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15453953', '14719824', '12170633', '15795801', '13151536']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6626574122881427
- 35 USC 102 Novelty (BERT): 0.5539843791037486
- Combined Prediction Score: 0.6517901089697034
- Mean Citation Score: 408.393822
- Max Citation Score: 421.8268
- Similarity Product: 324.271588392067

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test